<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1150</article-id><article-id pub-id-type="doi">10.25208/vdv1150</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL CASE REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>НАБЛЮДЕНИЕ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Experience of using ustekinumab in the treatment of a patient with HIV-associated psoriasis and anogenital warts</article-title><trans-title-group xml:lang="ru"><trans-title>Опыт применения устекинумаба в лечении псориаза у пациента с ВИЧ-инфекцией и аногенитальными бородавками</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4906-4297</contrib-id><contrib-id contrib-id-type="spin">7896-2629</contrib-id><name-alternatives><name xml:lang="en"><surname>Babkova</surname><given-names>M. I.</given-names></name><name xml:lang="ru"><surname>Бабкова</surname><given-names>М. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>mariababkova@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2952-9082</contrib-id><name-alternatives><name xml:lang="en"><surname>Arshinsky</surname><given-names>M. I.</given-names></name><name xml:lang="ru"><surname>Аршинский</surname><given-names>М. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kkvd80@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2633-1452</contrib-id><name-alternatives><name xml:lang="en"><surname>Frolova</surname><given-names>Z. V.</given-names></name><name xml:lang="ru"><surname>Фролова</surname><given-names>З. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>frolowazoya@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0149-1115</contrib-id><name-alternatives><name xml:lang="en"><surname>Chudina</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Чудина</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>olya_chudina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7657-0833</contrib-id><name-alternatives><name xml:lang="en"><surname>Mitrofanova</surname><given-names>J. S.</given-names></name><name xml:lang="ru"><surname>Митрофанова</surname><given-names>Ю. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kkvd80@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9598-3120</contrib-id><name-alternatives><name xml:lang="en"><surname>Batalova</surname><given-names>S. K.</given-names></name><name xml:lang="ru"><surname>Баталова</surname><given-names>С. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kkvdv@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Regional dermatovenerologic dispensary</institution></aff><aff><institution xml:lang="ru">Краевой кожно-венерологический диспансер</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-12-23" publication-format="electronic"><day>23</day><month>12</month><year>2021</year></pub-date><volume>97</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>94</fpage><lpage>100</lpage><history><date date-type="received" iso-8601-date="2020-07-09"><day>09</day><month>07</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-08-20"><day>20</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Babkova M.I., Arshinsky M.I., Frolova Z.V., Chudina O.A., Mitrofanova J.S., Batalova S.K.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Бабкова М.И., Аршинский М.И., Фролова З.В., Чудина О.А., Митрофанова Ю.С., Баталова С.К.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Babkova M.I., Arshinsky M.I., Frolova Z.V., Chudina O.A., Mitrofanova J.S., Batalova S.K.</copyright-holder><copyright-holder xml:lang="ru">Бабкова М.И., Аршинский М.И., Фролова З.В., Чудина О.А., Митрофанова Ю.С., Баталова С.К.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/1150">https://vestnikdv.ru/jour/article/view/1150</self-uri><abstract xml:lang="en"><p>The article presents an analysis of the literature of patients with HIV infection suffering from psoriasis. The clinical picture, laboratory data, and treatment of a patient suffering from psoriasis, psoriatic arthritis, anogenital venereal warts associated with HIV infection are described. Against the background of the use of an IL 12.23 inhibitor, regression of anogenital warts, resolution of psoriatic rashes, and relief of articular syndrome were noted.</p></abstract><trans-abstract xml:lang="ru"><p>Псориаз — хроническое, иммунологически опосредованное, генетически обусловленное заболевание, зависящее от внешних факторов. В данной статье рассмотрены актуальные методы лечения псориаза на фоне ВИЧ-инфекции. Основной акцент направлен на применение генно-инженерной биологической терапии (инфликсимаб, адалимумаб, устекинумаб, секукинумаб, иксекизумаб), а также возможности использования препаратов у этой категории пациентов. Отмечено влияние ВИЧ-инфекции на ключевые звенья патогенеза псориаза. Представлен случай лечения пациента, страдающего псориазом, псориатическим артритом, аногенитальными венерическими бородавками, ассоциированными с ВИЧ-инфекцией, с применением блокатора ИЛ-12, -23, приведены данные лабораторных исследований, изложены результаты применения препарата: регресс аногенитальных бородавок, разрешение псориатических высыпаний, купирование суставного синдрома. К сожалению, на сегодняшний день не существует рекомендаций для лечения пациентов с псориазом на фоне ВИЧ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>psoriasis</kwd><kwd>psoriatic arthritis</kwd><kwd>anogenital venereal warts</kwd><kwd>human papillomavirus</kwd><kwd>HIV infection</kwd><kwd>ustekinumab</kwd><kwd>inhibitor of IL-12, -23.</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>псориаз</kwd><kwd>псориатический артрит</kwd><kwd>аногенитальные венерические бородавки</kwd><kwd>вирус папилломы человека</kwd><kwd>ВИЧ-инфекция</kwd><kwd>стелара</kwd><kwd>устикинумаб</kwd><kwd>ингибитор ИЛ 12, -23</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The work was done and published through financing at the place of work of the authors.</funding-statement><funding-statement xml:lang="ru">Работа выполнена и опубликована за счет финансирования по месту работы авторов.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Menon K, Van Voorhees AS, Bebo BF Jr, Gladman DD, Hsu S, Kalb RE, et al. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62(2):291–299. doi: 10.1016/j.jaad.2009.03.047</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>de Camargo CC, Tasca KI, Mendes MB, Miot HA, de Souza Ldo R. Prevalence of Anogenital Warts in Men with HIV/AIDS and Associated Factors. Open AIDS J. 2014;8:25–30. doi: 10.2174/1874613601408010025</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wang DM, Fernandez AP, Calabrese CM, Calabrese LH. Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma. Clin Exp Dermatol. 2019;44(1):113–115. doi: 10.1111/ced.13630</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Little RF, Pluda JM, Wyvill KM, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, et al. Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood. 2006;107(12):4650–4657. doi: 10.1182/blood-2005-11-4455</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Paparizos V, Rallis E, Kirsten L, Kyriakis K. Ustekinumab for the treatment of HIV psoriasis. J Dermatolog Treat. 2012;23(6):398–399. doi: 10.3109/09546634.2011.579085</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Saeki H, Ito T, Hayashi M, Fukuchi O, Umezawa Y, Nobeyama Y, Teruya K, et al. Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection. J Eur Acad Dermatol Venereol. 2015;29(8):1653–1655. doi: 10.1111/jdv.12531</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bardazzi F, Magnano M, Campanati A, Loconsole F, Carpentieri A, Potenza C, et al. Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience. Acta Derm Venereol. 2017;97(8):989–990. doi: 10.2340/00015555-2698</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Montazeri A, Kanitakis J, Bazex J. Psoriasis and HIV infection. Int J Dermatol. 1996;35(7):475–479. doi: 10.1111/j.1365-4362.1996.tb01658.x</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Menon K, Van Voorhees AS, Bebo BF Jr, Gladman DD, Hsu S, Kalb RE, et al; National Psoriasis Foundation. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62(2):291–299. doi: 10.1016/j.jaad.2009.03.047</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–994. doi: 10.1016/S0140-6736(14)61909-7</mixed-citation></ref></ref-list></back></article>
